ID   ENTP3_HUMAN             Reviewed;         529 AA.
AC   O75355; B2R8D0; G5E9N0; O60495; Q8N6K2;
DT   29-AUG-2001, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2006, sequence version 2.
DT   10-MAY-2017, entry version 142.
DE   RecName: Full=Ectonucleoside triphosphate diphosphohydrolase 3;
DE            Short=NTPDase 3;
DE            EC=3.6.1.5;
DE   AltName: Full=CD39 antigen-like 3;
DE   AltName: Full=Ecto-ATP diphosphohydrolase 3;
DE            Short=Ecto-ATPDase 3;
DE            Short=Ecto-ATPase 3;
DE   AltName: Full=Ecto-apyrase 3;
DE   AltName: Full=HB6;
GN   Name=ENTPD3; Synonyms=CD39L3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-496.
RC   TISSUE=Keratinocyte;
RX   PubMed=9676430; DOI=10.1006/geno.1998.5317;
RA   Chadwick B.P., Frischauf A.-M.;
RT   "The CD39-like gene family: identification of three new human members
RT   (CD39L2, CD39L3, and CD39L4), their murine homologues, and a member of
RT   the gene family from Drosophila melanogaster.";
RL   Genomics 50:357-367(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RC   TISSUE=Brain;
RX   PubMed=9675246; DOI=10.1016/S0167-4838(98)00063-6;
RA   Smith T.M., Kirley T.L.;
RT   "Cloning, sequencing, and expression of a human brain ecto-apyrase
RT   related to both the ecto-ATPases and CD39 ecto-apyrases.";
RL   Biochim. Biophys. Acta 1386:65-78(1998).
RN   [3]
RP   SEQUENCE REVISION.
RA   Smith T.M., Kirley T.L.;
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Esophagus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   VAL-24.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   MUTAGENESIS OF TRP-187; ASP-219 AND TRP-459.
RX   PubMed=10231536; DOI=10.1021/bi990171k;
RA   Smith T.M., Lewis Carl S.A., Kirley T.L.;
RT   "Mutagenesis of two conserved tryptophan residues of the E-type
RT   ATPases: inactivation and conversion of an ecto-apyrase to an ecto-
RT   NTPase.";
RL   Biochemistry 38:5849-5857(1999).
RN   [9]
RP   MUTAGENESIS OF ARG-67; ARG-143; ARG-146; GLU-182; ASN-191; SER-224 AND
RP   GLN-226.
RX   PubMed=11300774; DOI=10.1021/bi002711f;
RA   Yang F., Hicks-Berger C.A., Smith T.M., Kirley T.L.;
RT   "Site-directed mutagenesis of human nucleoside triphosphate
RT   diphosphohydrolase 3: the importance of residues in the apyrase
RT   conserved regions.";
RL   Biochemistry 40:3943-3950(2001).
RN   [10]
RP   DISULFIDE BONDS.
RX   PubMed=15966724; DOI=10.1021/bi047487z;
RA   Ivanenkov V.V., Meller J., Kirley T.L.;
RT   "Characterization of disulfide bonds in human nucleoside triphosphate
RT   diphosphohydrolase 3 (NTPDase3): implications for NTPDase structural
RT   modeling.";
RL   Biochemistry 44:8998-9012(2005).
CC   -!- FUNCTION: Has a threefold preference for the hydrolysis of ATP
CC       over ADP.
CC   -!- CATALYTIC ACTIVITY: A nucleoside 5'-triphosphate + 2 H(2)O = a
CC       nucleoside 5'-phosphate + 2 phosphate.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- INTERACTION:
CC       Q8N205:SYNE4; NbExp=3; IntAct=EBI-10187968, EBI-7131783;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75355-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75355-2; Sequence=VSP_054237;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in adult brain, pancreas, spleen and
CC       prostate. Moderate or low expression is seen in most tissues. Not
CC       expressed in liver and peripheral blood leukocytes.
CC   -!- SIMILARITY: Belongs to the GDA1/CD39 NTPase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF039917; AAC39884.1; -; mRNA.
DR   EMBL; AF034840; AAC09236.2; -; mRNA.
DR   EMBL; AK313322; BAG36127.1; -; mRNA.
DR   EMBL; AC104186; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64600.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64601.1; -; Genomic_DNA.
DR   EMBL; BC029869; AAH29869.1; -; mRNA.
DR   CCDS; CCDS2691.1; -. [O75355-1]
DR   CCDS; CCDS74919.1; -. [O75355-2]
DR   RefSeq; NP_001239.2; NM_001248.3. [O75355-1]
DR   RefSeq; NP_001278889.1; NM_001291960.1. [O75355-1]
DR   RefSeq; NP_001278890.1; NM_001291961.1. [O75355-2]
DR   UniGene; Hs.441145; -.
DR   ProteinModelPortal; O75355; -.
DR   SMR; O75355; -.
DR   BioGrid; 107394; 1.
DR   IntAct; O75355; 5.
DR   STRING; 9606.ENSP00000301825; -.
DR   BindingDB; O75355; -.
DR   ChEMBL; CHEMBL5897; -.
DR   iPTMnet; O75355; -.
DR   PhosphoSitePlus; O75355; -.
DR   BioMuta; ENTPD3; -.
DR   PaxDb; O75355; -.
DR   PeptideAtlas; O75355; -.
DR   PRIDE; O75355; -.
DR   Ensembl; ENST00000301825; ENSP00000301825; ENSG00000168032. [O75355-1]
DR   Ensembl; ENST00000445129; ENSP00000404671; ENSG00000168032. [O75355-2]
DR   Ensembl; ENST00000456402; ENSP00000401565; ENSG00000168032. [O75355-1]
DR   GeneID; 956; -.
DR   KEGG; hsa:956; -.
DR   UCSC; uc003ckd.5; human. [O75355-1]
DR   CTD; 956; -.
DR   GeneCards; ENTPD3; -.
DR   HGNC; HGNC:3365; ENTPD3.
DR   HPA; HPA071802; -.
DR   MalaCards; ENTPD3; -.
DR   MIM; 603161; gene.
DR   neXtProt; NX_O75355; -.
DR   OpenTargets; ENSG00000168032; -.
DR   PharmGKB; PA27800; -.
DR   eggNOG; KOG1386; Eukaryota.
DR   eggNOG; COG5371; LUCA.
DR   GeneTree; ENSGT00550000074435; -.
DR   HOGENOM; HOG000059572; -.
DR   HOVERGEN; HBG018982; -.
DR   InParanoid; O75355; -.
DR   KO; K01510; -.
DR   OMA; NPCYPQN; -.
DR   OrthoDB; EOG091G05FZ; -.
DR   PhylomeDB; O75355; -.
DR   TreeFam; TF332859; -.
DR   BRENDA; 3.1.3.31; 2681.
DR   Reactome; R-HSA-8850843; Phosphate bond hydrolysis by NTPDase proteins.
DR   GeneWiki; ENTPD3; -.
DR   GenomeRNAi; 956; -.
DR   PRO; PR:O75355; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000168032; -.
DR   CleanEx; HS_ENTPD3; -.
DR   ExpressionAtlas; O75355; baseline and differential.
DR   Genevisible; O75355; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0102490; F:8-oxo-dGTP phosphohydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0017110; F:nucleoside-diphosphatase activity; TAS:Reactome.
DR   GO; GO:0017111; F:nucleoside-triphosphatase activity; TAS:Reactome.
DR   GO; GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0009134; P:nucleoside diphosphate catabolic process; IEA:Ensembl.
DR   GO; GO:0009143; P:nucleoside triphosphate catabolic process; IEA:Ensembl.
DR   InterPro; IPR000407; GDA1_CD39_NTPase.
DR   PANTHER; PTHR11782; PTHR11782; 1.
DR   Pfam; PF01150; GDA1_CD39; 1.
DR   PROSITE; PS01238; GDA1_CD39_NTPASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Complete proteome;
KW   Disulfide bond; Glycoprotein; Hydrolase; Magnesium; Membrane;
KW   Nucleotide-binding; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    529       Ectonucleoside triphosphate
FT                                diphosphohydrolase 3.
FT                                /FTId=PRO_0000209910.
FT   TOPO_DOM      1     22       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     23     43       Helical. {ECO:0000255}.
FT   TOPO_DOM     44    485       Extracellular. {ECO:0000255}.
FT   TRANSMEM    486    506       Helical. {ECO:0000255}.
FT   TOPO_DOM    507    529       Cytoplasmic. {ECO:0000255}.
FT   ACT_SITE    182    182       Proton acceptor. {ECO:0000250}.
FT   CARBOHYD     81     81       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    149    149       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    238    238       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    381    381       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    392    392       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    402    402       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    454    454       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     92    116       {ECO:0000269|PubMed:15966724}.
FT   DISULFID    261    308       {ECO:0000269|PubMed:15966724}.
FT   DISULFID    289    334       {ECO:0000269|PubMed:15966724}.
FT   DISULFID    347    353       {ECO:0000269|PubMed:15966724}.
FT   DISULFID    399    422       {ECO:0000269|PubMed:15966724}.
FT   VAR_SEQ     452    529       VGNSSIAWSLGYMLSLTNQIPAESPLIRLPIEPPVFVGTLA
FT                                FFTAAALLCLAFLAYLCSATRRKRHSEHAFDHAVDSD ->
FT                                E (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054237.
FT   VARIANT      24     24       I -> V (in dbSNP:rs17852714).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_070813.
FT   VARIANT     264    264       R -> Q (in dbSNP:rs34266806).
FT                                /FTId=VAR_061384.
FT   VARIANT     440    440       E -> D (in dbSNP:rs4470483).
FT                                /FTId=VAR_027541.
FT   VARIANT     496    496       A -> V (in dbSNP:rs1047855).
FT                                {ECO:0000269|PubMed:9676430}.
FT                                /FTId=VAR_027542.
FT   VARIANT     505    505       L -> F (in dbSNP:rs3733167).
FT                                /FTId=VAR_027543.
FT   MUTAGEN      67     67       R->G: Increase of activity.
FT                                {ECO:0000269|PubMed:11300774}.
FT   MUTAGEN     143    143       R->A: Loss of activity.
FT                                {ECO:0000269|PubMed:11300774}.
FT   MUTAGEN     143    143       R->K: Increase of activity.
FT                                {ECO:0000269|PubMed:11300774}.
FT   MUTAGEN     146    146       R->N: No effect.
FT                                {ECO:0000269|PubMed:11300774}.
FT   MUTAGEN     146    146       R->P: Increase of ATPase activity,
FT                                decrease of ADPase activity.
FT                                {ECO:0000269|PubMed:11300774}.
FT   MUTAGEN     146    146       R->T: Increase of activity.
FT                                {ECO:0000269|PubMed:11300774}.
FT   MUTAGEN     182    182       E->D: Complete loss of activity.
FT                                {ECO:0000269|PubMed:11300774}.
FT   MUTAGEN     182    182       E->Q: Complete loss of activity.
FT                                {ECO:0000269|PubMed:11300774}.
FT   MUTAGEN     187    187       W->A: Complete loss of activity.
FT                                {ECO:0000269|PubMed:10231536}.
FT   MUTAGEN     191    191       N->A: Loss of ATPase activity, increase
FT                                of ADPase activity.
FT                                {ECO:0000269|PubMed:11300774}.
FT   MUTAGEN     219    219       D->E: Increase of activity.
FT                                {ECO:0000269|PubMed:10231536}.
FT   MUTAGEN     224    224       S->A: Complete loss of activity.
FT                                {ECO:0000269|PubMed:11300774}.
FT   MUTAGEN     226    226       Q->A: Loss of activity.
FT                                {ECO:0000269|PubMed:11300774}.
FT   MUTAGEN     459    459       W->A: Increase of activity, especially
FT                                the ATP hydrolysis.
FT                                {ECO:0000269|PubMed:10231536}.
SQ   SEQUENCE   529 AA;  59105 MW;  5043CF0202978B88 CRC64;
     MFTVLTRQPC EQAGLKALYR TPTIIALVVL LVSIVVLVSI TVIQIHKQEV LPPGLKYGIV
     LDAGSSRTTV YVYQWPAEKE NNTGVVSQTF KCSVKGSGIS SYGNNPQDVP RAFEECMQKV
     KGQVPSHLHG STPIHLGATA GMRLLRLQNE TAANEVLESI QSYFKSQPFD FRGAQIISGQ
     EEGVYGWITA NYLMGNFLEK NLWHMWVHPH GVETTGALDL GGASTQISFV AGEKMDLNTS
     DIMQVSLYGY VYTLYTHSFQ CYGRNEAEKK FLAMLLQNSP TKNHLTNPCY PRDYSISFTM
     GHVFDSLCTV DQRPESYNPN DVITFEGTGD PSLCKEKVAS IFDFKACHDQ ETCSFDGVYQ
     PKIKGPFVAF AGFYYTASAL NLSGSFSLDT FNSSTWNFCS QNWSQLPLLL PKFDEVYARS
     YCFSANYIYH LFVNGYKFTE ETWPQIHFEK EVGNSSIAWS LGYMLSLTNQ IPAESPLIRL
     PIEPPVFVGT LAFFTAAALL CLAFLAYLCS ATRRKRHSEH AFDHAVDSD
//
